BlackRock’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-535,248
| Closed | -$260K | – | 5401 |
|
|
2020
Q4 | $260K | Buy |
535,248
+765
| +0.1% | +$386 | ﹤0.01% | 4438 |
|
|
2020
Q3 | $290K | Sell |
534,483
-4,173
| -0.8% | -$3K | ﹤0.01% | 4345 |
|
|
2020
Q2 | $371K | Sell |
538,656
-3,980,038
| -88% | -$3.2M | ﹤0.01% | 4268 |
|
|
2020
Q1 | $3.81M | Sell |
4,518,694
-95,010
| -2% | -$136K | ﹤0.01% | 3457 |
|
|
2019
Q4 | $7.57M | Buy |
4,613,704
+19,133
| +0.4% | +$28.7K | ﹤0.01% | 3376 |
|
|
2019
Q3 | $5.1M | Buy |
4,594,571
+123,770
| +3% | +$143K | ﹤0.01% | 3475 |
|
|
2019
Q2 | $5.54M | Buy |
4,470,801
+1,332,048
| +42% | +$1.7M | ﹤0.01% | 3503 |
|
|
2019
Q1 | $4.52M | Sell |
3,138,753
-111,895
| -3% | -$166K | ﹤0.01% | 3447 |
|
|
2018
Q4 | $3.83M | Buy |
3,250,648
+24,163
| +0.7% | +$35.9K | ﹤0.01% | 3482 |
|
|
2018
Q3 | $4.36M | Buy |
3,226,485
+68,168
| +2% | +$108K | ﹤0.01% | 3537 |
|
|
2018
Q2 | $7.23M | Buy |
3,158,317
+855,900
| +37% | +$1.65M | ﹤0.01% | 3382 |
|
|
2018
Q1 | $3.48M | Buy |
2,302,417
+127,118
| +6% | +$149K | ﹤0.01% | 3533 |
|
|
2017
Q4 | $1.66M | Sell |
2,175,299
-113,478
| -5% | -$101K | ﹤0.01% | 3751 |
|
|
2017
Q3 | $2.65M | Buy |
2,288,777
+113,447
| +5% | +$143K | ﹤0.01% | 3634 |
|
|
2017
Q2 | $3.79M | Sell |
2,175,330
-97,678
| -4% | -$208K | ﹤0.01% | 3546 |
|
|
2017
Q1 | $6M | Buy |
2,273,008
+2,264,545
| +26,758% | +$8.13M | ﹤0.01% | 3329 |
|
|
2016
Q4 | $36K | Sell |
8,463
-386
| -4% | -$1.27K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $23K | Hold |
8,849
| – | – | ﹤0.01% | 3256 |
|
|
2016
Q2 | $16K | Buy |
8,849
+5,650
| +177% | +$11.5K | ﹤0.01% | 3324 |
|
|
2016
Q1 | $7K | Buy |
3,199
+2,272
| +245% | +$5.14K | ﹤0.01% | 3295 |
|
|
2015
Q4 | $3K | Hold |
927
| – | – | ﹤0.01% | 3283 |
|
|
2015
Q3 | $6K | Hold |
927
| – | – | ﹤0.01% | 2965 |
|
|
2015
Q2 | $6K | Buy |
+927
| New | +$6.25K | ﹤0.01% | 3092 |
|
Other funds holding GEN
IC
TRCT
BlackRock's GEN Position: Q1 2021 in Review
BlackRock sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 535,248 shares — an estimated $260K sold.
BlackRock first reported a position in GEN in Q2 2015 and held it in 23 quarters. The position peaked at $7.57M in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- BlackRock reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- BlackRock sold 535,248 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $260K.
- BlackRock first reported a position in Genesis Healthcare, Inc. in Q2 2015 and held it in 23 quarters.
- BlackRock's Genesis Healthcare, Inc. position peaked at $7.57M in Q4 2019.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.